|
1
|
Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X,
Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and
characterization of human umbilical cord mesenchymal stem cells
with hematopoiesis-supportive function and other potentials.
Haematologica. 91:1017–1026. 2006.PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salem HK and Thiemermann C: Mesenchymal
stromal cells: Current understanding and clinical status. Stem
Cells. 28:585–596. 2010.PubMed/NCBI
|
|
4
|
Wang Y, Chen X, Cao W and Shi Y:
Plasticity of mesenchymal stem cells in immunomodulation:
Pathological and therapeutic implications. Nat Immunol.
15:1009–1016. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K, Wang D, Du WT, Han ZB, Ren H, Chi
Y, Yang SG, Zhu D, Bayard F and Han ZC: Human umbilical cord
mesenchymal stem cells hUC-MSCs exert immunosuppressive activities
through a PGE2-dependent mechanism. Clin Immunol. 135:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krampera M, Cosmi L, Angeli R, Pasini A,
Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G,
Vinante F, et al: Role for interferon-gamma in the immunomodulatory
activity of human bone marrow mesenchymal stem cells. Stem Cells.
24:386–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ryan JM, Barry F, Murphy JM and Mahon BP:
Interferon-gamma does not break, but promotes the immunosuppressive
capacity of adult human mesenchymal stem cells. Clin Exp Immunol.
149:353–363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
DelaRosa O, Lombardo E, Beraza A,
Mancheño-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, García
L, Abad JL, et al: Requirement of IFN-gamma-mediated indoleamine
2,3-dioxygenase expression in the modulation of lymphocyte
proliferation by human adipose-derived stem cells. Tissue Eng Part
A. 15:2795–2806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan WK, Lau AS, Li JC, Law HK, Lau YL and
Chan GC: MHC expression kinetics and immunogenicity of mesenchymal
stromal cells after short-term IFN-gamma challenge. Exp Hematol.
36:1545–1555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croitoru-Lamoury J, Lamoury FM, Caristo M,
Suzuki K, Walker D, Takikawa O, Taylor R and Brew BJ: Interferon-γ
regulates the proliferation and differentiation of mesenchymal stem
cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS
One. 6:e146982011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Wang L, Kikuiri T, Akiyama K, Chen
C, Xu X, Yang R, Chen W, Wang S and Shi S: Mesenchymal stem
cell-based tissue regeneration is governed by recipient T
lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laschober GT, Brunauer R, Jamnig A, Singh
S, Hafen U, Fehrer C, Kloss F, Gassner R and Lepperdinger G:
Age-specific changes of mesenchymal stem cells are paralleled by
upregulation of CD106 expression as a response to an inflammatory
environment. Rejuvenation Res. 14:119–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shenoy A and Blelloch RH: Regulation of
microRNA function in somatic stem cell proliferation and
differentiation. Nat Rev Mol Cell Biol. 15:565–576. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen Z, Zheng S, Zhou C, Yuan W, Wang J and
Wang T: Bone marrow mesenchymal stem cells for post-myocardial
infarction cardiac repair: MicroRNAs as novel regulators. J Cell
Mol Med. 16:657–671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin KK, Kim YS, Kim JY, Bae YC and Jung
JS: miR-137 controls proliferation and differentiation of human
adipose tissue stromal cells. Cell Physiol Biochem. 33:758–768.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paik S, Jung HS, Lee S, Yoon DS, Park MS
and Lee JW: miR-449a regulates the chondrogenesis of human
mesenchymal stem cells through direct targeting of lymphoid
enhancer-binding factor-1. Stem Cells Dev. 21:3298–3308. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clark EA, Kalomoiris S, Nolta JA and
Fierro FA: Concise review: MicroRNA function in multipotent
mesenchymal stromal cells. Stem Cells. 32:1074–1082. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomé M, López-Romero P, Albo C, Sepúlveda
JC, Fernández-Gutiérrez B, Dopazo A, Bernad A and González MA:
miR-335 orchestrates cell proliferation, migration and
differentiation in human mesenchymal stem cells. Cell Death Differ.
18:985–995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guennewig B, Roos M, Dogar AM, Gebert LF,
Zagalak JA, Vongrad V, Metzner KJ and Hall J: Synthetic
pre-microRNAs reveal dual-strand activity of miR-34a on TNF-α. RNA.
20:61–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vasanthan P, Govindasamy V, Gnanasegaran
N, Kunasekaran W, Musa S and Abu Kasim NH: Differential expression
of basal microRNAs' patterns in human dental pulp stem cells. J
Cell Mol Med. 19:566–580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Liu S and Cai Y: EGFR/MAPK signaling
regulates the proliferation of Drosophila renal and nephric stem
cells. J Genet Genomics. 42:9–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu Y, Loh YH, Li H, Cesana M, Ficarro SB,
Parikh JR, Salomonis N, Toh CX, Andreadis ST, Luckey CJ, et al:
Alternative splicing of MBD2 supports self-renewal in human
pluripotent stem cells. Cell Stem Cell. 15:92–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma F, Chen D, Chi Y, Chen F, Li X and Han
Z: The expression and role of miR-301a in human umbilical
cord-derived mesenchymal stromal cells. Cytotherapy. 15:1511–1516.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pandis I, Ospelt C, Karagianni N, Denis
MC, Reczko M, Camps C, Hatzigeorgiou AG, Ragoussis J, Gay S and
Kollias G: Identification of microRNA-221/222 and microRNA-323-3p
association with rheumatoid arthritis via predictions using the
human tumour necrosis factor transgenic mouse model. Ann Rheum Dis.
71:1716–1723. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu T, Huang C, Chen Z and Li J:
MicroRNA-323-3p: A new biomarker and potential therapeutic target
for rheumatoid arthritis. Rheumatol Int. 34:721–722. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the
tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res.
42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang R, Lee P, Lui VC, Chen Y, Liu X, Lok
CN, To M, Yeung KW and Wong KK: Silver nanoparticles promote
osteogenesis of mesenchymal stem cells and improve bone fracture
healing in osteogenesis mechanism mouse model. Nanomedicine.
11:1949–1959. 2015.PubMed/NCBI
|
|
32
|
Ng F, Boucher S, Koh S, Sastry KS, Chase
L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS and Tanavde
V: PDGF, TGF-beta, and FGF signaling is important for
differentiation and growth of mesenchymal stem cells (MSCs):
Transcriptional profiling can identify markers and signaling
pathways important in differentiation of MSCs into adipogenic,
chondrogenic, and osteogenic lineages. Blood. 112:295–307. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mojsilović S, Krstić A, Ilić V,
Okić-Đorđević I, Kocić J, Trivanović D, Santibañez JF, Jovčić G and
Bugarski D: IL-17 and FGF signaling involved in mouse mesenchymal
stem cell proliferation. Cell Tissue Res. 346:305–316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rodrigues M, Blair H, Stockdale L,
Griffith L and Wells A: Surface tethered epidermal growth factor
protects proliferating and differentiating multipotential stromal
cells from FasL-induced apoptosis. Stem Cells. 31:104–116. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tamama K and Barbeau DJ: Early growth
response genes signaling supports strong paracrine capability of
mesenchymal stem cells. Stem Cells Int. 2012:4284032012. View Article : Google Scholar : PubMed/NCBI
|
